首页 › 基金 › EMERALD ADVISERS, LLC › MIRM
EMERALD ADVISERS, LLC 对 MIRM 的持仓历史
MIRUM PHARMACEUTICALS INC · 医疗保健
EMERALD ADVISERS, LLC 在 Q3 2026 的 13F 申报中披露持有 MIRM(MIRUM PHARMACEUTICALS INC)469,771 股,市值约 US$40.2M,约占其申报组合的 1.10%,在其申报持仓中市值排名第 31 位。 EMERALD ADVISERS, LLC 最近 6 个申报季度中有 6 个季度披露了 MIRM 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
EMERALD ADVISERS, LLC 对 MIRM 的持仓演变
EMERALD ADVISERS, LLC 于 Q2 2025 首次披露 MIRM 持仓:305,766 股(约 US$15.6M)。 该持仓在 Q2 2026 达到峰值 468,295 股,市值约 US$54.8M。 在 6 次申报中,EMERALD ADVISERS, LLC 3 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 469,771 股、市值约 US$40.2M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 305.77K | $15.56M | 新进 |
| Q3 2025 | 369.60K | $27.10M | 增持 |
| Q4 2025 | 367.13K | $29.00M | 减持 |
| Q1 2026 | 397.26K | $36.70M | 增持 |
| Q2 2026 | 468.30K | $54.82M | 增持 |
| Q3 2026 | 469.77K | $40.16M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MIRM 与 13F 数据
MIRM(MIRUM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 MIRM,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MIRM 的基金
- Frazier Life Sciences Management, L.P. 7.68M 股 · $899.06M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M 股 · $146.20M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M 股 · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M 股 · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M 股 · $124.33M · Q2 2026
- BVF INC/IL 1.06M 股 · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K 股 · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M 股 · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M 股 · $68.30M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K 股 · $52.21M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 415.64K 股 · $48.66M · Q2 2026
- Palo Alto Investors LP 348.81K 股 · $40.83M · Q2 2026
更多关于 EMERALD ADVISERS, LLC
常见问题
How long has EMERALD ADVISERS, LLC held MIRM?
EMERALD ADVISERS, LLC has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is EMERALD ADVISERS, LLC's current position in MIRM?
As of Q3 2026, EMERALD ADVISERS, LLC holds 469.77K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $40.16M, representing 1.10% of its reported portfolio and ranking #31.
Has EMERALD ADVISERS, LLC been buying or selling MIRM?
In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC held unchanged its position in MIRM. The position peaked in Q2 2026 at 468.30K shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.